{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:40:49Z","timestamp":1787798449154,"version":"build-2784847793"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s12098-023-04905-1","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T08:02:16Z","timestamp":1699430536000},"page":"29-41","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Levetiracetam versus Phenobarbitone for Management of Neonatal Seizures: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"92","author":[{"given":"Jogender","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharti","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Meena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaivinder","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5194-9951","authenticated-orcid":false,"given":"Jitendra Kumar","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"4905_CR1","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1056\/NEJMra2300188","volume":"388","author":"E Yozawitz","year":"2023","unstructured":"Yozawitz E. Neonatal seizures. N Engl J Med. 2023;388:1692\u2013700.","journal-title":"N Engl J Med"},{"key":"4905_CR2","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/dmcn.13215","volume":"58","author":"L Kharoshankaya","year":"2016","unstructured":"Kharoshankaya L, Stevenson NJ, Livingstone V, et al. Seizure burden and neurodevelopmental outcome in neonates with hypoxic-ischemic encephalopathy. Dev Med Child Neurol. 2016;58:1242\u20138.","journal-title":"Dev Med Child Neurol"},{"key":"4905_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1177\/08830738221086107","volume":"37","author":"C Verwoerd","year":"2022","unstructured":"Verwoerd C, Limjoco J, Rajamanickam V, Knox A. Efficacy of levetiracetam and phenobarbital as first-line treatment for neonatal seizures. J Child Neurol. 2022;37:401\u20139.","journal-title":"J Child Neurol"},{"key":"4905_CR4","doi-asserted-by":"publisher","first-page":"fmab008","DOI":"10.1093\/tropej\/fmab008","volume":"67","author":"J Kumar","year":"2021","unstructured":"Kumar J, Meena J, Yadav J, Saini L. Efficacy and safety of phenobarbitone as first-line treatment for neonatal seizure: A systematic review and meta-analysis. J Trop Pediatr. 2021;67:fmab008.","journal-title":"J Trop Pediatr"},{"key":"4905_CR5","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s13312-019-1586-3","volume":"56","author":"VK Gowda","year":"2019","unstructured":"Gowda VK, Romana A, Shivanna NH, Benakappa N, Benakappa A. Levetiracetam versus phenobarbitone in neonatal seizures - a randomized controlled trial. Indian Pediatr. 2019;56:643\u20136.","journal-title":"Indian Pediatr"},{"key":"4905_CR6","doi-asserted-by":"publisher","first-page":"e20193182","DOI":"10.1542\/peds.2019-3182","volume":"145","author":"C Sharpe","year":"2020","unstructured":"Sharpe C, Reiner GE, Davis SL, et al. NEOLEV2 Investigators. Levetiracetam versus phenobarbital for neonatal seizures: A randomized controlled trial. Pediatrics. 2020;145:e20193182.","journal-title":"Pediatrics."},{"key":"4905_CR7","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.pedneo.2021.06.005","volume":"62","author":"Z-E Xu","year":"2021","unstructured":"Xu Z-E, Li W-B, Qiao M-Y, et al. Comparative efficacy of anti-epileptic drugs for neonatal seizures: A network meta-analysis. Pediatr Neonatol. 2021;62:598\u2013605.","journal-title":"Pediatr Neonatol"},{"key":"4905_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/epi.13365","volume":"57","author":"S Kaushal","year":"2016","unstructured":"Kaushal S, Tamer Z, Opoku F, Forcelli PA. Anticonvulsant drug-induced cell death in the developing white matter of the rodent brain. Epilepsia. 2016;57:727\u201334.","journal-title":"Epilepsia"},{"key":"4905_CR9","doi-asserted-by":"publisher","first-page":"3683548","DOI":"10.1155\/2019\/3683548","volume":"2019","author":"R Falsaperla","year":"2019","unstructured":"Falsaperla R, Mauceri L, Pavone P, et al. Short-term neurodevelopmental outcome in term neonates treated with phenobarbital versus levetiracetam: A single-center experience. Behav Neurol. 2019;2019:3683548.","journal-title":"Behav Neurol"},{"key":"4905_CR10","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/jp.2013.116","volume":"33","author":"NL Maitre","year":"2013","unstructured":"Maitre NL, Smolinsky C, Slaughter JC, Stark AR. Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures. J Perinatol. 2013;33:841\u20136.","journal-title":"J Perinatol"},{"key":"4905_CR11","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00381-014-2375-x","volume":"30","author":"M Komur","year":"2014","unstructured":"Komur M, Okuyaz C, Celik Y, et al. Neuroprotective effect of levetiracetam on hypoxic ischemic brain injury in neonatal rats. Childs Nerv Syst. 2014;30:1001\u20139.","journal-title":"Childs Nerv Syst"},{"key":"4905_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4103\/jpn.JPN_172_16","volume":"12","author":"R Falsaperla","year":"2017","unstructured":"Falsaperla R, Vitaliti G, Mauceri L, et al. Levetiracetam in neonatal seizures as first-line treatment: A prospective study. J Pediatr Neurosci. 2017;12:24\u20138.","journal-title":"J Pediatr Neurosci"},{"key":"4905_CR13","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1007\/s00431-023-04864-x","volume":"182","author":"G Gyandeep","year":"2023","unstructured":"Gyandeep G, Behura SS, Sahu SK, Panda SK. Comparison between phenobarbitone and levetiracetam as the initial anticonvulsant in preterm neonatal seizures - a pilot randomized control trial in developing country setup. Eur J Pediatr. 2023;182:2133\u20138.","journal-title":"Eur J Pediatr"},{"key":"4905_CR14","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1542\/hpeds.2021-006415","volume":"12","author":"S Susnerwala","year":"2022","unstructured":"Susnerwala S, Joshi A, Deshmukh L, Londhe A. Levetiracetam or phenobarbitone as a first-line anticonvulsant in asphyxiated term newborns? An open-label, single-center, randomized, controlled, pragmatic trial. Hosp Pediatr. 2022;12:647\u201353.","journal-title":"Hosp Pediatr"},{"key":"4905_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3329\/bjch.v42i2.37761","volume":"42","author":"AFM Pervez","year":"2018","unstructured":"Pervez AFM, Badal MFA, Nabi SN, et al. Randomized controlled trial between levetiracetam and phenobarbital in the treatment of neonatal seizure due to perinatal asphyxia. Bangladesh J Child Health. 2018;42:67\u201372.","journal-title":"Bangladesh J Child Health"},{"key":"4905_CR16","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.18203\/2320-6012.ijrms20161763","volume":"4","author":"S Perveen","year":"2016","unstructured":"Perveen S, Singh A, Upadhyay A, Singh N, Chauhan R. A randomized controlled trial on comparison of phenobarbitone and levetiracetam for the treatment of neonatal seizures: Pilot study. Int J Res Med Sci. 2016;4:2073\u20138.","journal-title":"Int J Res Med Sci"},{"key":"4905_CR17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.32677\/IJCH.2019.v06.i11.008","volume":"6","author":"A Prakash","year":"2019","unstructured":"Prakash A, Richa R, Sahni GS. Neonatal seizures \u2013 levetiracetam versus phenobarbital. Indian J Child Health. 2019;6:605\u20138.","journal-title":"Indian J Child Health"},{"key":"4905_CR18","doi-asserted-by":"publisher","first-page":"2333794X2211435","DOI":"10.1177\/2333794X221143572","volume":"9","author":"NE Akeel","year":"2022","unstructured":"Akeel NE, Suliman HA, Al-Shokary AH, et al. A comparative study of levetiracetam and phenobarbital for neonatal seizures as a first line treatment. Glob Pediatr Health. 2022;9:2333794X221143572.","journal-title":"Glob Pediatr Health"},{"key":"4905_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.siny.2015.01.005","volume":"20","author":"RA Shellhaas","year":"2015","unstructured":"Shellhaas RA. Continuous long-term electroencephalography: The gold standard for neonatal seizure diagnosis. Semin Fetal Neonatal Med. 2015;20:149\u201353.","journal-title":"Semin Fetal Neonatal Med"},{"key":"4905_CR20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.39604","volume":"4","author":"RW Hunt","year":"2021","unstructured":"Hunt RW, Liley HG, Wagh D, et al. Effect of treatment of clinical seizures vs electrographic seizures in full-term and near-term neonates: A randomized clinical trial. JAMA Netw Open. 2021;4:e2139604.","journal-title":"JAMA Netw Open"},{"key":"4905_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/epi.16815","volume":"62","author":"RM Pressler","year":"2021","unstructured":"Pressler RM, Cilio MR, Mizrahi EM, et al. The ILAE classification of seizures and the epilepsies: Modification for seizures in the neonate. Position paper by the ILAE Task Force on Neonatal Seizures. Epilepsia. 2021;62:615\u201328.","journal-title":"Epilepsia"},{"key":"4905_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al. RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"4905_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3329\/jdmc.v27i2.45831","volume":"27","author":"MTH Khan","year":"2020","unstructured":"Khan MTH, Rahman MM, Banerjee M, Uddin MZ, Nahar N, Akhter M. Comparative efficacy of phenobarbitone versus levetiracetam in the initial treatment of neonatal seizure. J Dhaka Med Coll. 2020;27:182\u20139.","journal-title":"J Dhaka Med Coll"},{"key":"4905_CR24","first-page":"25","volume":"31","author":"J Ghaffar","year":"2020","unstructured":"Ghaffar J, Riaz A, Uzair Virk A, Bhatti A. Comparative efficacy of intravenous levetiracetam vs phenobarbitone in neonatal seizures. Medical Forum Monthly. 2020;31:25\u20138.","journal-title":"Medical Forum Monthly"},{"key":"4905_CR25","doi-asserted-by":"crossref","unstructured":"Pressler RM, Abend NS, Auvin S, et al. Treatment of seizures in the neonate: Guidelines and consensus-based recommendations-Special report from the ILAE Task Force on Neonatal Seizures. Epilepsia. 2023;64:2550\u201370.","DOI":"10.1111\/epi.17745"},{"key":"4905_CR26","doi-asserted-by":"publisher","first-page":"F165","DOI":"10.1136\/fn.86.3.F165","volume":"86","author":"GB Boylan","year":"2002","unstructured":"Boylan GB, Rennie JM, Pressler RM, Wilson G, Morton M, Binnie CD. Phenobarbitone, neonatal seizures, and video-EEG. Arch Dis Child Fetal Neonatal Ed. 2002;86:F165\u201370.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"4905_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13052-021-01027-2","volume":"47","author":"R Falsaperla","year":"2021","unstructured":"Falsaperla R, Scalia B, Giugno A, et al. Treating the symptom or treating the disease in neonatal seizures: A systematic review of the literature. Ital J Pediatr. 2021;47:85.","journal-title":"Ital J Pediatr"},{"key":"4905_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/pr.2012.51","volume":"72","author":"CM Sharpe","year":"2012","unstructured":"Sharpe CM, Capparelli EV, Mower A, Farrell MJ, Soldin SJ, Haas RH. A seven-day study of the pharmacokinetics of intravenous levetiracetam in neonates: Marked changes in pharmacokinetics occur during the first week of life. Pediatr Res. 2012;72:43\u20139.","journal-title":"Pediatr Res"},{"key":"4905_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.seizure.2020.08.030","volume":"82","author":"M Hnaini","year":"2020","unstructured":"Hnaini M, Darwich M, Koleilat N, et al. High-dose levetiracetam for neonatal seizures: A retrospective review. Seizure. 2020;82:7\u201311.","journal-title":"Seizure"},{"key":"4905_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-022739","volume":"9","author":"G Favrais","year":"2019","unstructured":"Favrais G, Ursino M, Mouchel C, et al. Levetiracetam optimal dose-finding as first-line treatment for neonatal seizures occurring in the context of hypoxic-ischaemic encephalopathy (LEVNEONAT-1): Study protocol of a phase II trial. BMJ Open. 2019;9:e022739.","journal-title":"BMJ Open"}],"container-title":["Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-023-04905-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-023-04905-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-023-04905-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T03:36:14Z","timestamp":1733888174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-023-04905-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["4905"],"URL":"https:\/\/doi.org\/10.1007\/s12098-023-04905-1","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,8]]},"assertion":[{"value":"5 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}